Neoplasms - Diagnosis
Research News and Information

Saturday, November 21, 2009

Cancer screening behaviors and barriers in Asian Americans.

30 Oct 2009 OBJECTIVES: To determine differences in screening for routine physical exam and cancers among Chinese, Korean, Vietnamese, and Cambodian Americans. METHODS: The sample consisted of 2011 participants. Chi square was used to identify relationships ... Read more...

Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.

13 Oct 2009 The detection of circulating nucleic acids has long been explored for the diagnosis of a variety of clinical conditions. The aim of this study was to detect the cell-free mRNA expression of BIRC5 in patients with effusions and assess its potential ... Read more...

Comparison between a traditional single still image and a multiframe video image along the z-axis of the same microscopic field of interest in cytology: Which does contribute to telecytology?

29 Sep 2009 The limitation of cytologic still images is one of the reasons why telecytology has not met with widespread acceptance by the cytology community. Cytologic still image only displays a single depth of field, and this is a particularly acute problem ... Read more...

Latest indexed articles for 'Neoplasms - Diagnosis'

These are the very latest articles for this heading:

• The Canadian Triage Acuity Scale and oncological emergencies in the emergency department: the puzzle pieces may not fit. 29 Nov 2009
• Computerized utility assessment for cancer decision making: promises and pitfalls. 30 Oct 2009
• Cancer screening behaviors and barriers in Asian Americans. 30 Oct 2009
• Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions. 13 Oct 2009
• Comparison between a traditional single still image and a multiframe video image along the z-axis of the same microscopic field of interest in cytology: Which does contribute to telecytology? 29 Sep 2009
• Serum tumour markers: how to order and interpret them. 20 Sep 2009
• Multispectral fluorescence imaging. 14 Sep 2009
• Imaging tumor phenotype: 1 plus 1 is more than 2. 14 Sep 2009
• Catheter-associated thrombosis in patients with malignancy. 6 Sep 2009
• Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography. Sep 2009
• Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. 30 Aug 2009
• [Rational and precise design of novel fluorescence probes and their application to cellular response and in-vivo tumor imaging] 30 Aug 2009
• [Cancer genetics: estimation of the needs of the population in France for the next ten years] 30 Aug 2009
• Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions. 30 Aug 2009
• Imaging radiation biology for optimised radiation therapy. 30 Aug 2009
• Imaging tumour-bearing animals using clinical scanners. 30 Aug 2009
• An overview of the cancer burden for primary care physicians. 30 Aug 2009
• Preface. Cancer: what the primary care practitioner needs to know, part I. 30 Aug 2009
• Foreword. Cancer: what the primary care practitioner needs to know, part I. 30 Aug 2009
• Cancer metastasis networks and the prediction of progression patterns. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl